Hantz Financial Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.28M | Buy |
61,189
+12,104
| +25% | +$846K | 0.07% | 228 |
|
|
2025
Q1 | $3.61M | Buy |
49,085
+3,359
| +7% | +$247K | 0.06% | 245 |
|
|
2024
Q4 | $3M | Buy |
45,726
+1,212
| +3% | +$79.4K | 0.05% | 274 |
|
|
2024
Q3 | $3.47M | Buy |
44,514
+402
| +0.9% | +$31.3K | 0.06% | 259 |
|
|
2024
Q2 | $3.44M | Sell |
44,112
-1,126
| -2% | -$87.8K | 0.07% | 252 |
|
|
2024
Q1 | $3.07M | Sell |
45,238
-1,962
| -4% | -$133K | 0.06% | 274 |
|
|
2023
Q4 | $3.18M | Buy |
47,200
+46,986
| +21,956% | +$3.16M | 0.07% | 275 |
|
|
2023
Q3 | $14K | Hold |
214
| – | – | ﹤0.01% | 762 |
|
|
2023
Q2 | $15K | Sell |
214
-168
| -44% | -$11.8K | ﹤0.01% | 731 |
|
|
2023
Q1 | $27K | Buy |
382
+2
| +0.5% | +$141 | ﹤0.01% | 676 |
|
|
2022
Q4 | $26K | Sell |
380
-204
| -35% | -$14K | ﹤0.01% | 653 |
|
|
2022
Q3 | $32K | Buy |
584
+147
| +34% | +$8.06K | ﹤0.01% | 631 |
|
|
2022
Q2 | $29K | Sell |
437
-10
| -2% | -$664 | ﹤0.01% | 634 |
|
|
2022
Q1 | $30K | Sell |
447
-22
| -5% | -$1.48K | ﹤0.01% | 654 |
|
|
2021
Q4 | $27K | Sell |
469
-19
| -4% | -$1.09K | ﹤0.01% | 599 |
|
|
2021
Q3 | $29K | Buy |
488
+284
| +139% | +$16.9K | ﹤0.01% | 583 |
|
|
2021
Q2 | $12K | Hold |
204
| – | – | ﹤0.01% | 666 |
|
|
2021
Q1 | $10K | Sell |
204
-41
| -17% | -$2.01K | ﹤0.01% | 599 |
|
|
2020
Q4 | $12K | Hold |
245
| – | – | ﹤0.01% | 534 |
|
|
2020
Q3 | $13K | Buy |
245
+41
| +20% | +$2.18K | ﹤0.01% | 491 |
|
|
2020
Q2 | $11K | Buy |
+204
| New | +$11K | ﹤0.01% | 472 |
|